Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.

about

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.

Item

http://www.wikidata.org/entity/Q55356554

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.

@en

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.

@nl

type

Item

label

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.

@en

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.

@nl

prefLabel

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.

@en

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.

@nl

P1476

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.

@en

P2093

Ben-Li Su

http://www.w3.org/2001/XMLSchema#string

Hong Li

http://www.w3.org/2001/XMLSchema#string

Ji-Jiao Wang

http://www.w3.org/2001/XMLSchema#string

Le Bu

http://www.w3.org/2001/XMLSchema#string

Lu Xu

http://www.w3.org/2001/XMLSchema#string

Man-Na Zhang

http://www.w3.org/2001/XMLSchema#string

Ming Chen

http://www.w3.org/2001/XMLSchema#string

Nan Li

http://www.w3.org/2001/XMLSchema#string

Shao-Ling Yang

http://www.w3.org/2001/XMLSchema#string

Yi-Li Luo

http://www.w3.org/2001/XMLSchema#string

P2860

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells

Differential expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma

A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population.

Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis

Expression of pRb, p53, p16 and cyclin D1 and their clinical implications in urothelial carcinoma.

Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.

Pioglitazone use and risk of bladder cancer: population based cohort study.

P304

228-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/IJMS.22408

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29483814

http://www.w3.org/2001/XMLSchema#string

P932

5820852

http://www.w3.org/2001/XMLSchema#string